You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
龍虎榜數據 | 南天信息當日淨買入額最多,源深路4400萬掃3連板久其軟件

今日共24股漲停,連板股總數5只,上一交易日共46股漲停,漲停股晉級率10.86%。

個股方面,真視通與百亞股份跌停,市場連板高度被壓縮至3板,兩市超130只個股跌超9%,短線情緒接近冰點。板塊方面,多隻白馬股遭遇“業績殺”,大唐發電2連跌停,伊利股份、歌爾股份跌停,機構羣體情緒低迷,新能源汽車、風光儲等機構重倉區領跌。遊資羣體收縮戰線,短線活躍資金越來越聚集到信創板塊,中國軟件、南天信息等高位股波動劇烈。

下面我們來看下今日龍虎榜情況:

今日龍虎榜淨買入額榜前三為南天信息、盈方微、興齊眼藥,分別為1.41億元、1.05億元、5441.04萬元。

龍虎榜淨賣出額前三為國脈信息、壹石通、健帆生物,分別為8865.40萬元、8531.70萬元、7761.06萬元。

龍虎榜中涉及機構專用席位的個股中,當日淨買入額前三為南天信息、興齊眼藥、金陵飯店,分別為6204.71萬元、2754.55萬元、1747.65萬元。

龍虎榜中涉及機構專用席位的個股中,當日淨賣出額前三為壹石通、久其軟件、健帆生物,分別為1.10億元、4699.79萬元、4074.07萬元。

興齊眼藥關注點:

今日盤中大幅拉昇,一度逼近漲停,股價重返100元上方。

消息面上,公司0月26日晚間披露的第三季度報吿顯示,前三季度,公司實現營業收入10.04億元,同比增長30.37%;歸屬於上市公司股東的淨利潤2.03億元,同比增長29.96%;單季來看,公司第三季度實現營業收入4.04億元,同比增長31.08%;歸屬於上市公司股東的淨利潤8220.5萬元,同比增長8.26%。

廣發證券指出,目前全球範圍尚無針對近視的阿托品滴眼液獲批,公司的硫酸阿托品項目共包括3個I期臨牀試驗,包括0.01%阿托品的1年期,2年期臨牀,和0.02%及0.04%阿托品的2年期臨牀,產品線佈局全面,先發優勢明顯。

金陵飯店關注點:

1、10月27日,金陵飯店發佈2022年前三季度報吿,實現營業收入10.64億元,同比增長12.56%。歸屬於上市公司股東的淨利潤3015.1萬元,同比增長151.09%。

2、公司以酒店經營與管理為核心主業,涵蓋酒店物資貿易、物業管理、房屋租賃、食品研發與銷售、旅遊資源開發等多元化協同業務。

3、公司依託在高端餐飲的深厚積累和品牌優勢,以金陵特色菜餚為核心,針對市場需求加大對預製菜餚的研發力度,現階段先以較高端的家庭式宴會為切入點進行試製,即將推出年夜飯等產品,並延伸到生日宴、謝師宴、好友聚餐等細分領域。

機構重點關注個股:

康希諾:3日榜,滬股通淨買入1.25億元,3機構買入3.30億元

恆生電子:3日榜,4機構買入9.02億元,4機構賣出6.88億元

頂點軟件:3日榜,3機構買入2.07億元,1機構賣出5988.24萬元

南天信息:2機構買入9244.59萬元

興齊眼藥:深股通買入5737.81萬元,並賣出3529.81萬元;3機構買入7281.21萬元,2機構賣出4526.66萬元

金陵飯店:2機構買入2349.29萬元,2機構賣出1747.65萬元

科創信息:3機構買入5733.90萬元,3機構賣出4695.07萬元

盤龍藥業:1機構買入1579.90萬元

在龍虎榜中,涉及深股通專用席位的個股有4只,興齊眼藥的深股通專用席位淨買入額最大,淨買入2208萬元。

遊資操作動向:

今日相對有代表性的龍虎榜,還是信創為主,軟件、半導體、東數西算,參與的遊資主要是源深路、葛老大、粉葛等 。

源深路:淨買入久其軟件4409.43萬元

粉葛:淨買入盈方微5128.24萬元

作手新一:3日淨買入康希諾8048.93;淨賣出國脈科技3383.34萬元、直真科技55.29萬元

上塘路:3日淨買入同興達3777.39萬元;淨賣出真視通3314.40萬元

上海溧陽路:淨賣出真視通1035.31萬元

趙老哥:3日淨買入同興達1496.14萬元;單日淨買入浙江正特1165.41萬元,淨賣出三柏碩671.75萬元

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account